Today on in-pharmatechnologist.com   Merck HIV vaccine failure puts cold virus on trial Biovail keeps head above water Wacker expands further into biologics ProMetic techs for next generation hyperimmunes Pharmaceutical manufacturing: news in brief

Related Industry News   Aveo strategy ups chances of cancer drug success Good news follows bad news for InVentiv Drugs moving into the clinic: 34 'World's first' NanoImaging service centre opens

Breaking News on Pharmaceutical Technology
Daily  Friday 09 November 2007		Forward to a colleague

	Sponsored Link New filler/binder for ODT production Latest research shows that PALATINIT's galenIQ™ 720 and 721 are perfect alternatives for ODT formulations due to a fast disintegration time even without additional super-disintegrants... Click Here Access Full Stories Merck HIV vaccine failure puts cold virus on trial Merck & Co's failed HIV vaccine may actually increase the risk of infection and the latest data raises questions over whether the cold virus used as a delivery technique was at fault... Read Biovail keeps head above water Although the Canadian drug delivery specialist yesterday released third quarter results showing revenues down on last year, operating income is on the up despite generic competition and recent stumbles for its... Read Wacker expands further into biologics Biopharmaceutical contract manufacturer Wacker will be expanding its German facility in Jena for €15m ($22m) as it meets demand for biologics... Read ProMetic techs for next generation hyperimmunes Italian biopharmaceutical firm Kedrion is set to sign a deal with ProMetic BioTherapeutics to gain access to the firm's manufacturing technologies to increase yield and reduce prions in its hyperimmune products... Read Pharmaceutical manufacturing: news in brief In-PharmaTechnologist.com brings you a selection of other headlines from the pharmaceutical manufacturing industry... Read
	All News Headlines for: November | October | September
	Sponsored Link Oncological API Specialist ScinoPharm, specialized in manufacturing cGMP grade oncological APIs, offers fully integrated services to develop and manufacture final APIs capabilities including process research and development, analytical development and regulatory submission... Click Here
	Advertisement Related Industry News Aveo strategy ups chances of cancer drug success US-based Aveo Biopharmaceuticals is hoping to prove its R&D strategy can buck high industry failure rates when trying to design new cancer drugs and it seems to be working after its lead drug has passed a first-in-man... Read Good news follows bad news for InVentiv After losing a key Novartis contract and getting caught up in the Inyx collapse, Inventiv Health had good news this week when it reported its third quarter results... Read Drugs moving into the clinic: 34 The latest in a series of periodic roundups of drugs that have moved from preclinical research into clinical testing via the announcement of a Phase I trial or an application for a trial to industry regulators... Read 'World's first' NanoImaging service centre opens NanoImaging Services has opened what it claims is a first of its kind first fee-for-service imaging business to enable structural characterisation and validation of biological drugs throughout the development... Read Weekly Comment Big pharma lends a helping hand Despite often attracting a barrage of negative publicity, particularly in regard to a perception of putting profits before people, big pharma firms are still capable of showing their human side in times of crisis. Read Product Presentation Supremely Flexible: Spray Drying from Niro The new PSD-1 pharmaceutical spray dryer from Niro allows you to perform exacting R&D as well as production of IMP's and small-scale manufacturing with one and the same unit. Drying with the PHARMASD series of spray dryers gives you optimum control of product properties... Click Here Previous Headlines Genentech named facility of the year winner US biotechnology company Genentech is filling its trophy cupboard again after being named the winner of the 2007 Facility of the Year Award... Read West unscathed by Exubera shot - for now West Pharmaceutical Services, one of the two firms responsible for manufacturing Pfizer's failed Exubera device, recently turned in its third quarter financials, so far avoiding any major dent from the company's... Read Add PEG to make the drug go farther A US research team has found a way to increase drug distribution in the brain to fight the recurrence of human brain tumours... Read P&G in shock nasal spray exit Procter & Gamble (P&G) has this week terminated an agreement with Nastech to develop a nasally delivered version of Eli Lilly's osteoporosis drug Forteo (teriparatide), leaving its partner with no explanation... Read Sanofi pushes on with cell culture flu shot Sanofi Pasteur has kicked off Phase II trials of its cell culture-based seasonal flu vaccine in the US, part of a five year project with the US Department of Health and Human Services (HHS)... Read Product Information - brochures, Web centers The Safe'n'Sound Passive Safety Device for Prefilled Syringes - Product Presentation A Review of Dissolution tests with the Flow Through Method - Application Notes Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Cleanroom, safety equipment, supplies Contract services (outsourcing) Drug delivery systems Ingredients, excipients and raw materials IT solutions Lab equipment & consumables Packaging machinery & supplies Processing (automation, control, separation...) QA/QC & validation Tabletting, coating & ancillary equipment

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@In-PharmaTechnologist.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com